We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nanoparticles Enhance Scorpion Venom Anticancer Properties

By LabMedica International staff writers
Posted on 27 Apr 2009
Researchers have found that linking a candidate chemotherapeutic drug to a nanoparticle delivery system more than doubled the effectiveness of the drug on cultures of brain tumor cells.

The drug of interest was chlorotoxin, a small peptide isolated form scorpion venom. More...
Chlorotoxin affects brain cells through its interaction with a protein called MMP-2, which allows the penetration of normal and tumor cells through tissue barriers. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins that are activated when cleaved by extracellular proteinases. Chlorotoxin exerts a dual effect on MMP-2: it inhibits the enzymatic activity of MMP-2 and causes a reduction in the surface expression of MMP-2.

Investigators at the University of Washington (Seattle, USA) attached chlorotoxin to nanoparticles comprising an iron oxide nanoparticle core conjugated with an amine-functionalized poly(ethylene glycol) silane. Nanoparticle bound and unbound chlorotoxin were administered to cultures of mouse brain cancer cells.

Results published in the January 19, 2009, issue of the journal Small revealed that the nanoparticles exhibited substantially enhanced cellular uptake and an invasion inhibition rate of nearly 98% as compared to the 45% invasion inhibition rate of the unbound chlorotoxin. Data from flow cytometry analysis, transmission electron microscopy, and fluorescent imaging showed that the chlorotoxin-enabled nanoparticles deactivated the cells' membrane-bound matrix MMP-2.
"People talk about the treatment being more effective with nanoparticles but they do not know how much, maybe 5% or 10%," said senior author Dr. Miqin Zhang, professor of materials science and engineering at the University of Washington. "This was quite a surprise to us."

Related Links:
University of Washington


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.